Global Health Limited (MEDANTA) — Capital Reinvestment Ratio
Latest as of September 2025:
1.26x
Global Health Limited (MEDANTA) has a Capital Reinvestment Ratio of 1.26x as of September 2025, meaning it reinvests 1% of its operating cash flow (Rs3.29 Billion) in capital expenditures (Rs4.13 Billion). See MEDANTA cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.26x
Capex / Operating Cash Flow
Operating Cash Flow
Rs3.29 Billion
INR
Capital Expenditures
Rs4.13 Billion
INR
Data as of
Sep 2025
Most recent filing
Global Health Limited Capital Reinvestment Ratio (2019–2026)
This chart tracks Global Health Limited's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Global Health Limited (2019–2026)
Year-by-year Capital Reinvestment Ratio for Global Health Limited from 2019 to 2026. For live market cap and broader valuation context, see MEDANTA market cap.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 1.30x | Rs7.53 Billion | Rs9.79 Billion | ▲ +56.9% |
| 2025 | 0.83x | Rs6.24 Billion | Rs5.17 Billion | ▲ +81.9% |
| 2024 | 0.46x | Rs6.12 Billion | Rs2.79 Billion | ▲ +24.3% |
| 2023 | 0.37x | Rs6.45 Billion | Rs2.36 Billion | ▼ -58.5% |
| 2022 | 0.88x | Rs3.11 Billion | Rs2.74 Billion | ▲ +46.3% |
| 2021 | 0.60x | Rs2.42 Billion | Rs1.46 Billion | ▼ -43.9% |
| 2020 | 1.08x | Rs1.75 Billion | Rs1.88 Billion | ▼ -44.6% |
| 2019 | 1.94x | Rs1.54 Billion | Rs3.00 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow